Keynote Presentation: Uncovering Clinical Advances with thyTregs™ to Expand the Frontiers of Treg Therapy

• Unveiling clinical data on Thytech’s thyTregs™ therapy preventing transplant rejection in heart transplant children
• Exploring thymic-derived allogeneic Treg therapeutic potential across multiple
• indications including Chron’s disease
• Discussing the escalation capacity of thyTregs™ to accelerate therapeutic success

Speakers:

Rafael Correa-Rocha

Chief Scientific Officer

ThyTech